Abstract
Introduction/BackgroundThe challenge when performing cytoreductive surgery (CRS) for advanced ovarian cancer is to balance the benefits (obtaining complete CRS) and risks (perioperative complications). The aim of this study was to...
Highlights
In the future these outcomes should be discussed to minimize complications and improve quality of care within the nation
A total of 2382 patients met the inclusion criteria corresponding to 2458 surgical procedures. 1027 patients underwent PCS and 1355 patients underwent ICS, a third group contained patients with both PCS and ICS (n=76 )
Complications with re-invention were significantly higher in PCS compared to ICS (5.7% vs. 3.6% respectively, p =0.048), but complete cytoreductive surgery (CRS) was achieved more often in PCS compared to ICS (69.7% vs 62.1% respectively
Summary
In the future these outcomes should be discussed to minimize complications and improve quality of care within the nation. Introduction/Background The challenge when performing cytoreductive surgery (CRS) for advanced ovarian cancer is to balance the benefits (obtaining complete CRS) and risks (perioperative complications). The aim of this study was to report short term postoperative morbidity and mortality in relation to surgical outcome in patients undergoing primary cytoreductive surgery(PCS) and/or interval cytoreductive (ICS) surgery in 8 gynaeco-oncological regions in the Netherlands. Methodology Data from the prospective Dutch Gynecological Oncology Audit(DGOA) data base were used for this retrospective analysis with population-based data.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
